Last week in Kauai, at the Team Elite Executive trip, Nu Skin unveiled ageLOC^® TR90™, a highly-anticipated weight management and body shaping system that is scheduled to begin rolling out in the second half of the year. The ageLOC TR90 system is the latest in ageLOC’s anti-aging products, which focuses on providing nutritional and skin care solutions that target the sources of aging.  

“We were extremely pleased with the positive reaction of our top sales leaders as we released the details of our new ageLOC TR90 system,” said Truman Hunt, president and chief executive officer. “We anticipate the global limited-time offer in the second half of the year will be our largest product launch ever.”

AgeLOC TR90 includes four proprietary nutritional products and science-based eating plan, along with lifestyle suggestions, to help consumers reach their goals. The nutritional supplements in the ageLOC weight management system are designed to target three important areas for weight management: healthy metabolism, lean muscle and appetite control.

“Our research shows that many weight management programs focus on maximizing pounds lost, whether the weight comes from fat, muscle or both,” said Joseph Chang, Ph.D., chief scientific officer and executive vice president, product development. “In contrast, we are focusing our system on improving overall body composition—with the ideal of supporting the maintenance of lean muscle while promoting healthy, overall weight loss.”

Nu Skin plans to introduce the ageLOC TR90 system as a limited-time offer at its global convention in October, with regional introductions taking place throughout 2014.

Please Note: This webpage contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies and new product introductions; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following: any failure of planned initiatives or products to generate interest among distributors and consumers; risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations; risk that order cancellations, product returns, and cannibalization of other product sales will exceed management’s expectations; and regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or sell a product in a market if it is unable to register the product in a timely manner under applicable regulatory requirement.

The forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission.  The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.